How much does pemetinib/pemetinib cost per year?

Pemigatinib/Pemigatinib is an oral targeted therapy drug mainly used to treat advanced cholangiocarcinoma with FGFR2 gene rearrangement. FGFR2 gene rearrangement is a common molecular mutation in cholangiocarcinoma. The cost for a patient to take pemetinib for one year varies based on a variety of factors, including drug dosage, treatment duration, purchasing channel, and the patient's region. Therefore, the exact cost of one year's use cannot be given.

According to information from different sources, the price of pemetinib varies. In some cases, the price of each box of pemetinib sold in China may be around RMB 30,000. Each box contains 14 tablets, each with a dose of 4.5 mg. According to the recommended daily dose (13.5 mg) in a 21-day cycle, the monthly medication cost may reach about 100,000 yuan. However, this is only a rough estimate and actual costs may vary depending on the patient's specific condition and medication regimen.

In addition, it should be noted that pemetinib is a targeted therapy drug targeting specific gene fusions and is mainly used to treat malignant tumors such as cholangiocarcinoma. Before use, patients should consult a professional physician to determine whether pemetinib is suitable for use and to understand detailed medication instructions and precautions. At the same time, because drug prices may be high, patients and family members should fully understand their affordability when considering use, and consult their doctors or pharmacists for detailed information on costs.

Overall, the cost of one year's use of pemetinib varies based on many factors, and it's impossible to give an exact figure. Patients should fully communicate with professional doctors when considering use and understand the detailed medication plan and cost.